DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cardiovascular Diseases
- Hypertension
- Vascular Diseases
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Participant)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
DENEX system developed by Kalos Medical Inc. is a renal denervation system to efficiently block the sympathetic nerve of the kidney with minimal invasive procedure. It was developed to block the sympathetic nerves distributed in blood vessel wall by delivering high frequency energy to the renal arte...
DENEX system developed by Kalos Medical Inc. is a renal denervation system to efficiently block the sympathetic nerve of the kidney with minimal invasive procedure. It was developed to block the sympathetic nerves distributed in blood vessel wall by delivering high frequency energy to the renal artery for the purpose of treating hypertension.
Tracking Information
- NCT #
- NCT04535050
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Konstantinos Tsioufis, Professor National and Kapodistrian University of Athens, Greece Study Director: Felix Mahfoud, Professor Saarland University Hospital, Homburg Study Director: Massimo Volpe, Professor Sapienza University of Rome
Get Well Soon